TCT 检测在宫颈疾病诊断中的应用

王芳

（陕西省延安市志丹县人民医院，陕西 延安，717500）

浏览次数：124次 下载次数：377次

摘要：

目的 探讨宫颈液基薄层细胞学技术（TCT）在宫颈疾病诊断中的应用价值。方法 选择2013年2月到2016年1月在我院妇科门诊因宫颈可疑异常就诊患者3 000例，都进行TCT 检测与宫颈组织活检，判断TCT检测宫颈疾病的诊断应用价值。 结果 在3 000例宫颈可疑异常就诊患者中，TCT检测显示宫颈正常者2 300例，异常者700例，异常率为23.33%。宫颈组织活检确诊宫颈正常者2 266 例，异常者734 例，异常率为24.47%。以病理确诊结果为金标准，TCT检测在宫颈疾病诊断中的灵敏度和特异度分别为94.55%（694/734）和99.74%（2 260/2 266）。结论 TCT 检测在宫颈疾病诊断中的应用具有较高的检出率、灵敏度和特异度，且检测损伤少，所以可以作为宫颈癌前病变的检查方法之一。

关键词：宫颈液基薄层细胞学技术；宫颈癌前病变；宫颈组织活检

中图分类号：R737.33文献标志码：A文章编号：2096-1413(2017)20-0136-02

Application of TCT detection in the diagnosis of cervical diseases
WANG Fang
(Zhidan County People``s Hospital, Yan``an 717500, China)

ABSTRACT: Objective To investigate the application value of  TCT detection in the diagnosis of cervical diseases. Methods From February 2013 to January 2016, 3 000 cases of patients with abnormal cervical in our hospital were selected, and all the patients were detected by TCT and cervical biopsy, so as to determine the diagnostic value of TCT detection for cervical disease. Results In the 3 000 cases of patients with abnormal cervical, there were 2 300 cases of normal cervix and 700 cases of abnormal by TCT test, the exception rate was 23.33%; and there were 2 266 cases of normal cervix and 734 cases of abnormal by cervical biopsy, the exception rate was 24.47%. Using the pathological diagnosis as the gold standard, the sensitivity and specificity of TCT detection in cervical disease diagnosis were 94.55% (694/734) and 99.74% (2 260/2 266) respectively. Conclusion TCT detection has a high detection rate, sensitivity and specificity in the diagnosis of cervical disease, and less damage detection, which can be used as the one inspection method for precancerous lesions of uterine cervix.
KEYWORDS: thinprep cytology test; precancerous lesion of cervix; cervical biopsy

参考文献：
[1] 李宇,邱桂清.TCT 联合HR-HPV对宫颈癌前病变的诊断价值[J]. 浙江临床医学,2016,18(7):1344-1345.
[2] 孙爱密,戴婵娟,叶秀明,等.HPV联合薄层宫颈液基细胞学检查在诊断子宫颈病变中的价值[J].浙江临床医学,2016,18(5):952-953,959.


[3] 霍文婧,梁茂盛,韩存芝.人乳头瘤病毒联合薄层液基细胞检查在子宫颈疾病筛查中的应用[J].肿瘤研究与临床,2016,28(2):103-106.
[4] 冯炜,戴宝贞,陈英.内蒙古自治区已婚育龄妇女生殖系统相关疾病现状调查[J].中国计划生育学杂志,2012,20(7):467-469.
[5] 张海燕.永宁社区育龄妇女对宫颈疾病防治知识认知及需求调查 [J].中国现代药物应用,2016,10(1):286-288.
[6] YIN G,LI J,ZHU T,et al.The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study[J].World J Surg On原 col,2012,10(1):168-173.
[7] 周利敏,郑炜,张敦兰,等.HPV-DNA 检测在宫颈上皮内瘤变诊断和预后中的作用[J].公共卫生与预防医学,2013,24(3):118-119.
[8] 王艳英,黄秀娟,范文双,等.宫颈癌的常见病因及防护措施[J].中国伤残医学,2011,19(10):79-80.
[9] 鲁秀仙.宫颈超薄液基细胞学检查联合HPV 检测在宫颈癌前病变筛查中的使用价值[J].中国保健营养,2016,26(4):355-356.
[10] 蔡静,许华,阿娜尔古丽,等.南疆维吾尔族宫颈癌防治中健康教育干预必要性的调查研究[J].中华疾病控制杂志,2014,18(8):799-800.
[11] 田岩岩.TCT细胞学检测结合病理分析在诊断宫颈疾病中的应用[J].世界最新医学信息文摘,2016,16(27):147.
[12] 顾免澜.不同人群宫颈疾病患病情况以及对宫颈疾病筛查可接受程度分析[J].淮海医药,2016,34(2):196,201.
[13] 田玉旺,张立英,许春伟,等.液基细胞学与传统巴氏制片技术在宫颈癌及癌前病变早期筛查中的应用[J].中国医药导报,2015,12(28),120-123.